Rap2a is a novel target gene of p53 and regulates cancer cell migration and invasion

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• The p53 transcription factor is a key regulator of cellular processes including cell cycle control, DNA repair, and apoptosis.
• Emerging evidence suggests p53's involvement in regulating cell invasion and migration.
• Rap2a, a small GTPase, influences cell adhesion, migration, and proliferation via signaling pathways.

Purpose of the Study:

• To investigate the relationship between p53 and Rap2a.
• To determine if Rap2a is a direct target of p53.
• To elucidate the role of Rap2a in cancer cell invasion and metastasis.

Main Methods:

• DNA damage induction in cells.
• Chromatin immunoprecipitation (ChIP) assays to assess p53 binding to the Rap2a promoter.
• Quantitative real-time PCR (qRT-PCR) to measure Rap2a mRNA levels.
• Western blotting to analyze protein expression and phosphorylation (Akt).
• Cell migration and invasion assays.
• Matrix metalloproteinase (MMP) activity assays.

Main Results:

• Rap2a is identified as a novel target gene of p53.
• Rap2a expression is induced in a p53-dependent manner upon DNA damage.
• p53 directly binds to the Rap2a promoter, activating its transcription.
• Rap2a is significantly upregulated in various tumor types.
• Ectopic Rap2a expression enhances cancer cell migration, invasion, and MMP2/MMP9 activity.
• Rap2a inactivation inhibits cell invasion and MMP2/MMP9 activity.
• Rap2a regulates the phosphorylation of Akt (p-Akt).

Conclusions:

• p53 directly induces Rap2a expression following DNA damage.
• Rap2a plays a crucial role in promoting cancer cell migration, invasion, and metastasis.
• Rap2a enhances these processes, at least in part, by upregulating p-Akt.